Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel Disease | Zendy

Nidah S. Khakoo | Zendy; Ayanna Lewis | Zendy; Giovanni A. Roldan | Zendy; Alex Al Khoury | Zendy; Maria A. Quintero | Zendy; Amar R. Deshpande | Zendy; David H. Kerman | Zendy; Oriana M. Damas | Zendy; María T. Abreu | Zendy

Open Access

Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel Disease

Author(s) -

Nidah S. Khakoo,

Ayanna Lewis,

Giovanni A. Roldan,

Alex Al Khoury,

Maria A. Quintero,

Amar R. Deshpande,

David H. Kerman,

Oriana M. Damas,

María T. Abreu

Publication year - 2021

Publication title -

crohn s and colitis 360

Language(s) - English

Resource type - Journals

ISSN - 2631-827X

DOI - 10.1093/crocol/otab028

Subject(s) - calprotectin , medicine , inflammatory bowel disease , feces , gastroenterology , clostridium difficile , disease , antibiotics , biology , paleontology , microbiology and biotechnology

Background Limited data exist on adherence to fecal calprotectin (FCP) testing in patients with inflammatory bowel disease. Methods Completion rates for patients who had at least one FCP test ordered (n = 3082) and a subgroup with C-reactive protein, complete blood count, and Clostridium difficile tests also ordered (n = 1563) were analyzed. Results More patients completed blood than stool tests, with FCP having the poorest adherence of all tests analyzed. Older patients had higher FCP completion rates. No differences were noted in completion rates across age, gender, or ethnicity for blood tests. Conclusions Further studies are needed to develop strategies that improve the uptake of FCP.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research